Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice

Atherosclerosis

Volumn 225, Issue 2, 2012, Pages 328-334

  Boué, Stéphanie ^a   Tarasov, Kirill ^b   Jänis, Minna ^b   Lebrun, Stefan ^a   Hurme, Reini ^b   Schlage, Walter ^a   Lietz, Michael ^a   Vuillaume, Gregory ^a   Ekroos, Kim ^b   Steffen, Yvonne ^a   Peitsch, Manuel C ^a   Laaksonen, Reijo ^b   Hoeng, Julia ^a  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

^b Zora Biosciences Oy   (Finland)

Author keywords

Apolipoprotein E knockout mice; Atherosclerosis; Lipidomics; Smoking

Indexed keywords

AMINO ACID; APOLIPOPROTEIN E; CERAMIDE; CEREBROSIDE; CHOLESTEROL; CHOLESTEROL ESTER; CIGARETTE SMOKE; GALACTOSYLCERAMIDE; GLUCOSYLCERAMIDE; LIPIDOME; LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SPHINGOMYELIN; TRIACYLGLYCEROL;

AIR; AMINO ACID METABOLISM; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ARCH; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPIDOMICS; LIPOPROTEIN BLOOD LEVEL; LIVER; MASS SPECTROMETRY; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN MICROARRAY; ROBOTICS; SMOKING; TRANSCRIPTOMICS; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; AORTA, THORACIC; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; LIPIDS; LIVER; MASS SPECTROMETRY; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLAQUE, ATHEROSCLEROTIC; TIME FACTORS; TOBACCO SMOKE POLLUTION;

EID: 84869508905     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.09.032     Document Type: Article

References (22)

1. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. The surgeon general 2010, Surgeon General, p. 351-434.
2. Howard G., Wagenknecht L.E., Burke G.L., et al. Cigarette smoking and progression of atherosclerosis: the atherosclerosis risk in communities (ARIC) study. J Am Med Assoc 1998, 279:119-124.
3. Huxley R.R., Yatsuya H., Lutsey P.L., et al. Impact of age at smoking initiation, dosage, and time since quitting on cardiovascular disease in african americans and whites: the atherosclerosis risk in communities study. Am J Epidemiol 2012, 175:816-826.
4. Gepner A.D., Piper M.E., Johnson H.M., et al. Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J 2011, 161:145-151.
5. Castelli W.P. Lipids, risk factors and ischaemic heart disease. Atherosclerosis 1996, 124(Suppl.):S1-S9.
6. Meikle P.J., Wong G., Tsorotes D., et al. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 2011, 31:2723-2732.
7. Ekroos K., Janis M., Tarasov K., et al. Lipidomics: a tool for studies of atherosclerosis. Curr Atheroscler Rep 2010, 12:273-281.
8. Stegemann C., Drozdov I., Shalhoub J., et al. Comparative lipidomics profiling of human atherosclerotic plaques. Circ Cardiovasc Genet 2011, 4:232-242.
9. O'Neill T.P. Apolipoprotein E-deficient mouse model of human atherosclerosis. Toxicol Pathol 1997, 25:20-21.
10. von Holt K., Lebrun S., Stinn W., et al. Progression of atherosclerosis in the Apo E-/- model: 12-month exposure to cigarette mainstream smoke combined with high-cholesterol/fat diet. Atherosclerosis 2009, 205:135-143.
11. Stahlman M., Ejsing C.S., Tarasov K., et al. High-throughput shotgun lipidomics by quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:2664-2672.
12. Gentleman R.C., Carey V.J., Bates D.M., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80.
13. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3. [Article3].
14. R: a language and environment for statistical computing 2007, Team RDC.
15. Irizarry R.A., Hobbs B., Collin F., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
16. Huang da W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37:1-13.
17. Frost-Pineda K., Liang Q., Liu J., et al. Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. Nicotine Tob Res 2011, 13:182-193.
18. Yang J., Yang S., Gao X., Yuan Y.J. Integrative investigation of lipidome and signal pathways in human endothelial cells under oxidative stress. Mol Biosyst 2011, 7:2428-2440.
19. Demirjian L., Abboud R.T., Li H., Duronio V. Acute effect of cigarette smoke on TNF-alpha release by macrophages mediated through the erk1/2 pathway. Biochim Biophys Acta 2006, 1762:592-597.
20. Bietrix F., Lombardo E., van Roomen C.P., et al. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice. Arterioscler Thromb Vasc Biol 2010, 30:931-937.
21. Cheng D., Jenner A.M., Shui G., et al. Lipid pathway alterations in Parkinson's disease primary visual cortex. PLoS One 2011, 6:e17299.
22. Ehret G.B., Munroe P.B., Rice K.M., et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011, 478:103-109.